Filing Details
- Accession Number:
- 0001104659-20-031567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-10 21:25:46
- Reporting Period:
- 2020-03-06
- Accepted Time:
- 2020-03-10 21:25:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1674254 | Jonathan Kafer | C/O Akorn, Inc. 1925 W. Field Court, Suite 300 Lake Forest IL 60045 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-06 | 11,088 | $1.02 | 193,257 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The amount of shares beneficially owned includes 188,846 unvested Restricted Stock Units (RSUs) and 4,411 shares owned outright.
Billionaire Hedge Funds
